Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions

Michael Paulzen*, Ekkehard Haen, Gerhard Gruender, Sarah E. Lammertz, Benedikt Stegmann, Koen R. J. Schruers, Sebastian Walther, Georgios Schoretsanitis

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)
Original languageEnglish
Pages (from-to)803-809
JournalJournal of Psychopharmacology
Issue number8
Publication statusPublished - Aug 2016


  • Therapeutic drug monitoring
  • risperidone
  • amlodipine
  • metoprolol
  • CYP2D6
  • interaction
  • pharmacokinetics

Cite this